Picture: Peter Shanks.

COVID-19 vaccine technology benefits devils

Since the emergence of the facial fungal disease during the mid-1990s that has decimated Tasmanian devil populations in the wild, scientists have been working on developing a vaccine that can protect the species and slow the spread of the fatal cancer. Although there was limited success with an earlier immunotherapy trial, that saw some captive-bred […]

Continue Reading

Solving a piece of the DFTD puzzle

Scientists have long puzzled over how and why the fatal facial tumour disease that continues to ravage populations of Tasmanian devils in the wild became a transmissible cancer, given tumours usually grow exclusively in the organism where their cell of origin derives from. An international study that involved scientists from the CeMM Research Centre for […]

Continue Reading

Devil vaccine a step closer

The results of an international study published recently in Scientific Reports has confirmed the fatal facial tumour disease that has decimated populations of Tasmanian devils in the wild for over 20 years, can be cured using immunotherapy. Led by the University of Tasmania’s Menzies Institute for Medical Research, the study involved scientists from the Universities […]

Continue Reading